Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CAR T cells in solid tumors: challenges and opportunities.
Marofi F, Motavalli R, Safonov VA, Thangavelu L, Yumashev AV, Alexander M, Shomali N, Chartrand MS, Pathak Y, Jarahian M, Izadi S, Hassanzadeh A, Shirafkan N, Tahmasebi S, Khiavi FM. Marofi F, et al. Among authors: thangavelu l. Stem Cell Res Ther. 2021 Jan 25;12(1):81. doi: 10.1186/s13287-020-02128-1. Stem Cell Res Ther. 2021. PMID: 33494834 Free PMC article. Review.
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy.
Marofi F, Rahman HS, Thangavelu L, Dorofeev A, Bayas-Morejón F, Shirafkan N, Shomali N, Chartrand MS, Jarahian M, Vahedi G, Mohammed RN, Shahrokh S, Akbari M, Khiavi FM. Marofi F, et al. Among authors: thangavelu l. Stem Cell Res Ther. 2021 Mar 22;12(1):200. doi: 10.1186/s13287-021-02251-7. Stem Cell Res Ther. 2021. PMID: 33752707 Free PMC article. Review.
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies.
Marofi F, Saleh MM, Rahman HS, Suksatan W, Al-Gazally ME, Abdelbasset WK, Thangavelu L, Yumashev AV, Hassanzadeh A, Yazdanifar M, Motavalli R, Pathak Y, Naimi A, Baradaran B, Nikoo M, Khiavi FM. Marofi F, et al. Among authors: thangavelu l. Stem Cell Res Ther. 2021 Jul 2;12(1):374. doi: 10.1186/s13287-021-02462-y. Stem Cell Res Ther. 2021. PMID: 34215336 Free PMC article. Review.
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons.
Naimi A, Mohammed RN, Raji A, Chupradit S, Yumashev AV, Suksatan W, Shalaby MN, Thangavelu L, Kamrava S, Shomali N, Sohrabi AD, Adili A, Noroozi-Aghideh A, Razeghian E. Naimi A, et al. Among authors: thangavelu l. Cell Commun Signal. 2022 Apr 7;20(1):44. doi: 10.1186/s12964-022-00854-y. Cell Commun Signal. 2022. PMID: 35392976 Free PMC article. Review.
Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction.
Mardi A, Shirokova AV, Mohammed RN, Keshavarz A, Zekiy AO, Thangavelu L, Mohamad TAM, Marofi F, Shomali N, Zamani A, Akbari M. Mardi A, et al. Among authors: thangavelu l. Cancer Cell Int. 2022 Apr 29;22(1):168. doi: 10.1186/s12935-022-02585-z. Cancer Cell Int. 2022. PMID: 35488303 Free PMC article. Review.
91 results